Chlamydia (Chlamydial Infection) Treatment
Covered by Aetna in California

Doxycycline 100mg orally twice daily × 7 days — first-line per 2021 CDC STI Treatment Guidelines (update formalized as current standard through 2024); superior microbiologic cure rates vs. single-dose azithromycin for urogenital chlamydia, particularly rectal chlamydia; must complete full course and abstain from sex until 7 days after completing the regimen

Azithromycin 1g orally in a single dose — now listed as an alternative (downgraded from co-first-line in 2021 CDC update); appropriate for patients with doxycycline allergy, concerns about adherence to 7-day course, or pregnancy (azithromycin is preferred in pregnancy along with amoxicillin 500mg TID × 7 days); levofloxacin 500mg once daily × 7 days for doxycycline-intolerant, non-pregnant adults

Yes — generic doxycycline 100mg is Tier 1 on the Aetna CA formulary, typically $4–$10 for a 14-tablet course at CVS, Walgreens, or Walmart Pharmacy. Azithromycin 1g (2 tablets of 500mg) is also Tier 1 generic, often under $5. No prior authorization required for either.

The CDC 2021 STI Treatment Guidelines (which remain the operative 2024 standard) elevated doxycycline 100mg BID × 7 days to sole first-line therapy for uncomplicated urogenital chlamydia in non-pregnant adolescents and adults, based on superior cure rates over single-dose azithromycin — particularly at rectal sites. Patients with symptoms of PID, epididymo-orchitis, or fever are referred in-person. Retesting is recommended 3 months post-treatment per CDC. Neonatal exposure management requires in-person pediatric evaluation.

Yes. California's expedited partner therapy (EPT) law — implemented under SB-306 — explicitly authorizes Dr. Bhavsar to write a prescription for your partner(s) based on your diagnosis, without the partner appearing for an examination. You provide the partner's name; a separate prescription is written and filled at any retail pharmacy. EPT applies to chlamydia, gonorrhea, and trichomoniasis. EPT does not substitute for a full STI panel — partners are encouraged to get tested, but can receive treatment immediately rather than waiting for their own appointment.

The CDC's 2021 STI Treatment Guidelines (current as of 2024) elevated doxycycline 100mg twice daily × 7 days as the sole first-line treatment after clinical trial data demonstrated significantly lower microbiological failure rates compared to single-dose azithromycin — particularly for rectal chlamydia, where azithromycin cure rates were only 74–82% vs. >97% for doxycycline. Single-dose azithromycin remains an alternative for patients with documented doxycycline allergy or pregnancy, but is no longer co-first-line for the general population. The shift also reduces selection pressure for azithromycin-resistant organisms.

No. A TDMD telehealth visit is fully sufficient for clinical evaluation and treatment. Dr. Bhavsar fulfills California's mandatory chlamydia reporting obligation (within 7 days per Title 17 CCR §2500) directly from the telehealth visit. You do not need a separate in-person appointment. If you receive a positive result from an at-home test kit (e.g., Nurx, Wisp, or LABCORP direct), bring the result to your TDMD visit and treatment can be initiated and reported the same day.

Yes, CDC recommends retesting 3 months after chlamydia treatment — not because antibiotics fail (cure rates exceed 97% with doxycycline), but because the most common reason for a second positive is reinfection from an untreated partner or a new exposure. If retesting at 3 months is not possible, retest at the next clinical encounter within 12 months. Patients with cervical chlamydia during pregnancy should also retest 3–4 weeks after treatment and again at 3 months, due to risk of neonatal transmission.

Yes. Aetna commercial plans cover telehealth visits for Chlamydia (Chlamydial Infection) in California. TeleDirectMD (Dr. Parth Bhavsar, MD, NPI: 1104323203) is an in-network telehealth provider with Aetna in California. Your standard Aetna telehealth copay applies — typically $10–$40 for most commercial plans. If clinically appropriate, your prescription is sent to your California pharmacy immediately after your visit.

Most Aetna commercial plans in California have telehealth copays of $10–$40. Often $0–$20 for employer plans. Your exact cost depends on your specific plan and whether your deductible has been met. Log into your Aetna member portal or call the member services number on your card to verify your telehealth copay before your chlamydia treatment visit. Self-pay is always available for a flat $49 if you prefer to skip insurance.

If your specific Aetna plan is not in-network with TeleDirectMD in California, or if your deductible has not yet been met, you can book as a self-pay patient for a flat $49 fee — same physician, same quality of care, no insurance needed. You may also be eligible to submit an out-of-network claim to Aetna for partial reimbursement depending on your plan's out-of-network benefit.

TeleDirectMD typically offers same-day and next-day video visits. Book at teledirectmd.com/book-online and select a time that works for you. Most patients are seen within a few hours of booking during business hours. Your chlamydia treatment symptoms are evaluated by Dr. Bhavsar, MD — not a nurse practitioner or PA — ensuring you receive a board-certified clinical assessment.

Yes. TeleDirectMD is operated by Dr. Parth Bhavsar, MD (NPI: 1104323203), a board-certified Family Medicine physician. TeleDirectMD is LegitScript certified, HIPAA compliant, and is contracted as an in-network telehealth provider with Aetna in California. Claims are billed using standard CPT codes (99213/99214) and submitted electronically to Aetna.

Yes. Telehealth visits with a licensed physician are qualified medical expenses eligible for FSA (Flexible Spending Account) and HSA (Health Savings Account) payment. If your Aetna plan applies your deductible first, your FSA or HSA card can be used to pay your portion. The $49 self-pay option is also FSA/HSA eligible.